CurveBeam AI Limited

Research CurveBeam AI Limited (CVB.AX) on Bullrun: market cap AUD 9.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is AUD 9.30M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/an/an/an/a-0.04n/an/an/a
FY2024AUD 6.53M-AUD 23.10M-AUD 22.18M46.1%-0.08AUD 6.45MAUD 15.93MAUD 38.92M
FY2023AUD 8.06M-AUD 51.23M-AUD 22.52M54.5%-0.85AUD 5.16MAUD 14.84M-AUD 48.10M
FY2022AUD 7.42M-AUD 9.62M-AUD 10.50M53.8%-0.03n/an/aAUD 0

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-17AUD 9.30Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 AUD.

About CurveBeam AI Limited

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is CurveBeam AI Limited's market cap?

CurveBeam AI Limited's market capitalization is AUD 9.30M.

What does CurveBeam AI Limited do?

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools.